Intensive support recommendations for critically-ill patients with suspected or confirmed COVID-19 infection.

Autor: Corrêa TD; Hospital Israelita Albert Einstein , São Paulo , SP , Brazil ., Matos GFJ; Hospital Israelita Albert Einstein , São Paulo , SP , Brazil ., Bravim BA; Hospital Israelita Albert Einstein , São Paulo , SP , Brazil ., Cordioli RL; Hospital Israelita Albert Einstein , São Paulo , SP , Brazil ., Garrido ADPG; Hospital Israelita Albert Einstein , São Paulo , SP , Brazil ., Assuncao MSC; Hospital Israelita Albert Einstein , São Paulo , SP , Brazil ., Barbas CSV; Hospital Israelita Albert Einstein , São Paulo , SP , Brazil ., Timenetsky KT; Hospital Israelita Albert Einstein , São Paulo , SP , Brazil ., Rodrigues RDR; Hospital Israelita Albert Einstein , São Paulo , SP , Brazil ., Guimarães HP; Hospital Israelita Albert Einstein , São Paulo , SP , Brazil ., Rabello Filho R; Hospital Israelita Albert Einstein , São Paulo , SP , Brazil ., Lomar FP; Hospital Israelita Albert Einstein , São Paulo , SP , Brazil ., Scarin FCC; Hospital Israelita Albert Einstein , São Paulo , SP , Brazil ., Batista CL; Hospital Israelita Albert Einstein , São Paulo , SP , Brazil ., Pereira AJ; Hospital Israelita Albert Einstein , São Paulo , SP , Brazil ., Guerra JCC; Hospital Israelita Albert Einstein , São Paulo , SP , Brazil ., Carneiro BV; Hospital Israelita Albert Einstein , São Paulo , SP , Brazil ., Nawa RK; Hospital Israelita Albert Einstein , São Paulo , SP , Brazil ., Brandão RM; Hospital Israelita Albert Einstein , São Paulo , SP , Brazil ., Pesaro AEP; Hospital Israelita Albert Einstein , São Paulo , SP , Brazil ., Silva Júnior M; Hospital Israelita Albert Einstein , São Paulo , SP , Brazil ., Carvalho FRT; Hospital Israelita Albert Einstein , São Paulo , SP , Brazil ., Silva CSM; Hospital Israelita Albert Einstein , São Paulo , SP , Brazil ., Almeida ACF; Hospital Israelita Albert Einstein , São Paulo , SP , Brazil ., Franken M; Hospital Israelita Albert Einstein , São Paulo , SP , Brazil ., Pesavento ML; Hospital Israelita Albert Einstein , São Paulo , SP , Brazil ., Eid RAC; Hospital Israelita Albert Einstein , São Paulo , SP , Brazil ., Ferraz LJR; Hospital Israelita Albert Einstein , São Paulo , SP , Brazil .
Jazyk: English; Portuguese
Zdroj: Einstein (Sao Paulo, Brazil) [Einstein (Sao Paulo)] 2020 Jun 03; Vol. 18, pp. eAE5793. Date of Electronic Publication: 2020 Jun 03 (Print Publication: 2020).
DOI: 10.31744/einstein_journal/2020AE5793
Abstrakt: In December 2019, a series of patients with severe pneumonia were identified in Wuhan, Hubei province, China, who progressed to severe acute respiratory syndrome and acute respiratory distress syndrome. Subsequently, COVID-19 was attributed to a new betacoronavirus, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Approximately 20% of patients diagnosed as COVID-19 develop severe forms of the disease, including acute hypoxemic respiratory failure, severe acute respiratory syndrome, acute respiratory distress syndrome and acute renal failure and require intensive care. There is no randomized controlled clinical trial addressing potential therapies for patients with confirmed COVID-19 infection at the time of publishing these treatment recommendations. Therefore, these recommendations are based predominantly on the opinion of experts (level C of recommendation).
Databáze: MEDLINE
Externí odkaz: